Nigeria walks a tightrope as far as meeting the 2030 cervical cancer elimination target is concerned. With significant gaps ...

Pune: PCMC's plan to set up a dedicated cancer treatment facility gained some momentum two years after its announcement, as a ...

In rural areas, the arrival of high-speed internet is often a game-changer. Homes are more connected, businesses have new opportunities and telehealth becomes more accessible.

At a time when some countries are on track to eliminate cervical cancer, Canada is moving in the opposite direction. For health experts and survivors, including Ottawa advocate Liz Ellwood ...

MSD’s checkpoint inhibitor Keytruda has been cleared by the FDA for use in newly diagnosed cervical cancer patients with less severe disease, becoming the first anti-PD-1/PD-L1 immunotherapy for ...

Dr Sonia Golani provides essential insights into everything you need to know about HPV vaccines for cervical cancer prevention. Cervical cancer is one of the most preventable types of cancer, yet it ...

The US Food and Drug Administration (FDA) recently approved a first of its kind use-at-home cervical cancer screening tool. Known as “Teal Wand,” it allows women to collect their vaginal sample at ...

Self-collected samples to test for cervical cancer are a step in the right direction when it comes to addressing healthcare barriers, according to Rahma S. Mkuu, Ph.D., M.P.H., assistant professor in ...

THE number of women who died from cervical cancer in Davao City dropped from 88 in 2023 to 67 in 2024, according to the City Health Office (CHO). Dr. Sharlene Tan, district health physician at the CHO ...

Patients had a higher risk of recurrence if they had grade 3 tumors or tumors measuring at least 2 cm. New research suggests that patients with early-stage cervical cancer and no high-risk factors ...

Another story making headlines recently was an announcement from the FDA that could have a big impact on cervical cancer screenings. Andrea, tell us more about that. Garcia: Well, last Friday, the FDA ...